In Focus: IP, Regulation and Compliance
LSX C-Suite Challenges in Life Sciences Survey 2018
In this extract from the LSX C-Suite Challenges in Life Sciences Survey 2018, we focus on senior executive respondents’ perceptions of IP, compliance and regulatory issues. This includes their concerns about the impact of Brexit on the sector, the importance they place on IP protection, and the extent to which data protection features on senior leaders’ agendas. The LSX C-Suite Challenges in Life Sciences Survey 2018 has been designed to benchmark and give voice to the hurdles faced by C-level executives through key stages in the product and company development process.
The IP, Regulation and Compliance report section and white paper are kindly supported by intellectual property firm Marks & Clerk.
LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.